4.2 Article

Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies)

期刊

NEUROMUSCULAR DISORDERS
卷 10, 期 8, 页码 553-559

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/S0960-8966(00)00143-7

关键词

dysferlin; calpain 3; laminin; merosin; muscular dystrophy; muscle proteins; Western blotting

向作者/读者索取更多资源

Dysferlin is the protein product of the gene (DYFS) that is defective in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy. Calpain 3 is the muscle-specific member of the calcium activated neutral protease family and primary mutations in the CAPN3 gene cause limb girdle muscular dystrophy type 2A. The functions of both proteins remain speculative, Here we report a secondary reduction in calpain 3 expression in eight out of 16 patients with a primary dysferlinopathy and clinical features characteristic of limb girdle muscular dystrophy type 2B or Miyoshi myopathy. Previously CAPN3 analysis had been undertaken in three of these patients and two showed seemingly innocuous missense mutations, changing calpain 3 amino acids to those present in the sequences of calpains 1 and 2. These results suggest that there may be an association between dysferlin and calpain 3, and further analysis of both genes may elucidate a novel functional Interaction. In addition, an association was found between prominent expression of smaller forms of the 80 kDa fragment of laminin alpha2 chain (merosin) and dysferlin-deficiency. (C) 2000 Elsevier Science B.V. All lights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据